Is retatrutide legal? Only in two settings: Lilly’s clinical trials and its pre-approval expanded access program.[3][6] Retatrutide is not FDA-approved, Lilly says it cannot be legally sold or marketed for human use,[2] FDA says it cannot be used in compounding, and FDA has warned companies selling it as a “research” product.[1]
This page explains each part of that answer. It is general information, not legal advice. For the science and trial results, see the retatrutide profile.
Why selling retatrutide is illegal
Under US law, a new drug or biologic cannot be introduced into interstate commerce until FDA has approved or licensed it. For biologics, which is how Lilly plans to file retatrutide, the Public Health Service Act says no one may introduce a biological product into interstate commerce unless a biologics license is in effect.[4] Lilly plans to submit that application, a Biologics License Application (BLA), in the first quarter of 2027.[7]
Until then, retatrutide is an investigational drug. Lilly’s own wording is direct: it is “an investigational molecule that cannot be legally sold or marketed for human use.”[2]
Is “research peptide” retatrutide legal?
No, not when it is sold for people to use. FDA says it has warned companies that illegally sold unapproved drugs containing retatrutide, along with semaglutide, tirzepatide, survodutide and mazdutide, that were falsely labeled “for research purposes” or “not for human consumption.” These products were sold directly to consumers for human use, with dosing instructions.[1]
A “not for human consumption” label does not change what the product is or how it is marketed. FDA urges consumers not to buy these products, which it says are of unknown quality and may be harmful.[1]
There is also no way to know what is in the vial. A 2026 study of people describing their own use of unapproved retatrutide noted that product identity, purity and dose could not be verified.[8] The trial results reported for Lilly’s drug do not apply to these products.
For more on how these products are marketed, see our guides to research-use-only peptides and compounded vs research-grade peptides.
Can retatrutide be compounded?
No. FDA states that retatrutide “cannot be used in compounding under federal law.” It also notes that retatrutide is not a component of any FDA-approved drug and has not been found safe and effective for any condition.[1]
FDA has taken action at several points in the supply chain. It has warned:[1]
- telehealth companies for marketing unapproved drugs such as retatrutide, including directly to consumers
- ingredient (API) distributors for selling retatrutide to compounders
- outsourcing facilities for repackaging retatrutide
So a telehealth site or pharmacy offering “compounded retatrutide” is not offering a lawful product. This differs from semaglutide and tirzepatide, which are approved drugs and have their own compounding rules; see 503A vs 503B compounding and the GLP-1 compounding ban.
Red flags when retatrutide is offered online
FDA lists warning signs for weight-loss drugs sold online. Be cautious if a company:[1]
- claims its product is the same as an FDA-approved drug
- offers prices that seem too good to be true
- does not require screening and a prescription from a licensed doctor
- has no licensed doctor available to answer questions after you receive the medicine
- ships medicine that looks different from what was pictured, or arrives damaged or without instructions for use
With retatrutide, there is a simpler test: no lawful seller exists, so any offer to sell it for human use is a red flag on its own.
If you have already used it
A clinician needs to know to care for you safely. Tell your doctor what you took, how much and for how long, and bring the vial or packaging if you still have it. FDA encourages patients and health professionals to report side effects or quality problems to its MedWatch program.[1]
Is retatrutide a controlled substance?
No. Retatrutide does not appear on the DEA’s alphabetical list of controlled substances.[5] That means the limits on it come from FDA drug-approval law, not from drug-scheduling rules. It does not mean the products sold online are legal or safe. See our explainer on DEA peptide classification.
Is it legal to buy or possess retatrutide for personal use?
FDA’s published actions on retatrutide have been aimed at the companies that make, supply, market and sell it, not at individual buyers.[1] That is not the same as saying buying it is lawful or safe. You would be buying an unapproved drug of unknown quality from a seller FDA considers to be acting illegally. Rules on importing drugs and on possession can also vary; see peptide import laws and peptide legality by country.
The legal ways to get retatrutide
| Route | Who qualifies | How |
|---|---|---|
| Clinical trial | People who meet a trial’s criteria | Search ClinicalTrials.gov or ask a clinician |
| Expanded access | Adults with a BMI of 35 or more and two or more serious obesity-related complications | A doctor requests it from Lilly |
| Prescription | Nobody yet | Only after FDA approval |
Lilly says retatrutide is legally available only to participants in its clinical trials,[3] and since mid-2026 it has also offered single-patient expanded access.[6]
The expanded access program is narrow. Patients must be 18 or older, have a BMI of 35 or more despite the highest available dose of an approved weight-management drug, have at least two serious or life-threatening obesity-related complications, be unable to join a trial, and have discussed all standard options, including bariatric surgery, with their doctor.[6]
When could it become legal to prescribe?
Only after FDA approval. Lilly said in August 2026 that its data package was complete to support registrations for obesity, obstructive sleep apnea and knee osteoarthritis pain, with an FDA submission planned for early 2027.[7] The phase 3 TRIUMPH-1 trial behind that filing was published in 2026.[9] See when will retatrutide be available? for the likely review timeline.
Questions to ask a clinician
- Are there approved medicines that suit me while retatrutide is under review?
- Do I meet the criteria for a retatrutide trial or expanded access?
- If I have already used a “research” product, what should be checked?
For the clinical side, see is retatrutide safe? and the retatrutide dosage guide.
